Breaking News

Gamma Biosciences to acquire BioMagnetic Solutions

The company will operate independently but will leverage Gamma’s other operating companies, Astrea Bioseparations and ...

Catalent acquires Acorda manufacturing and packaging operations

Completion of the transaction is subject to customary closing conditions and is expected to occur in the first quarter ...

RoosterBio partners with Sartorius on scale up protocols

Both companies aim to use the data from this collaboration to provide co-learning and development opportunities to ...

The promise, challenge and evolution of cell and gene therapy

Cell and gene therapy treatments offer the hope of a cure for diseases that would otherwise result in a lifetime of ...

Cytiva delivers modular biologics factory to Lonza

The overall project was completed within its expected time range despite COVID-19 restrictions

Cognate plans manufacturing expansion in US and Europe

Build-out of the commercial manufacturing location will begin in 2021 with the goal of coming online as quickly as ...

Drug dose delivery development, manufacturing and commercialisation trends: part II

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central ...

Hovione launches formulation screening service

The service aims to enable fast progress to clinical supplies and minimal formulation changes before commercialisation

Planning law revolution: new opportunities for life science businesses

The life sciences industry is cautiously welcoming news of an overhaul in planning law in England and Wales that ...

Packaging prefilled syringes: solving the sterility conundrum

What’s the key to ensuring sterility when packaging prefilled syringes?

Technology to transform the capture and processing of drug safety data

The ultimate goal of pharmacovigilance is to prevent adverse drug reactions, thus maximising the benefit:risk ratio for ...

The industrial production of cell and gene therapies: part II

Dr Andrea Traube, Director of Market Development, Pharma, at OPTIMA pharma, and Dena Flamm, Business Development ...

AMRI New Mexico facility approved for BARDA network

The network is part of a US government initiative to improve preparedness capabilities

Recipharm signs manufacturing agreement with Enzymatica

ColdZyme is intended to treat and alleviate common cold and has already been launched in about 30 countries across ...

Inspiration and Learning

People

Reports